80wk Downtrend — falling+below (sma 4.52 vs px 1.65)
200wk Downtrend — falling+below (sma 6.08 vs px 1.65)
Funds Distributing — momZ +0.14 · 0.41→0.38
Earnings Headwind — ER in 14.387d · w1 med -5.9% (mag 2/3) · winRate 35.3% (rel 2/3) · n34
RS Breakdown — momZ +1.52 · low 0w×1.00 · vs industry
About Neuroone Medical Technologies Corp
NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, trigeminal neuralgia, Parkinson's disease, dystonia, essential tremors, and chronic… Read full Trend Edge analysis →
Sector: Healthcare
Industry: Medical Devices
Exchange: NASDAQ
IPO Date: September 18, 2017
Headquarters: 7599 Anagram Drive, Eden Prairie, MN, United States, 55344
Founder-Led: Yes — Mark Christianson (Co-Founder, Business Development Director, and Medical Sales Liaison)
Key Metrics
Current Price
$1.70
Market Cap
$16.1M
Float
5.8M
Shares Outstanding
8.7M
Price/Sales (TTM)
1.27
vs. Analyst Target
+484.3% to analyst PT
Profit Margin
-52.23%
Operating Margin (TTM)
-87.86%
Revenue (TTM)
$12.7M
Dividend Rate
None
Analyst Target Price
$9.93 (1 analysts)
Financial History
Annual Revenue & Earnings History
Year
Revenue
Net Income
Gross Profit
EBITDA
2020
$1.9M
-$13.6M
$1.9M
-$4.9M
2021
$178,146
-$9.9M
-$97,749
-$9.8M
2022
$171,169
-$10.0M
-$70,794
-$9.9M
2023
$2.0M
-$11.9M
$456,517
-$11.7M
2024
$3.5M
-$12.3M
$1.1M
-$11.8M
2025
$12.1M
-$3.6M
$8.1M
-$3.0M
Recent Quarterly Revenue & Net Income
Quarter
Revenue
Net Income
Jun 2025
$1.7M
-$1.5M
Sep 2025
$2.7M
-$1.6M
Dec 2025
$2.9M
-$1.4M
Mar 2026
$2.4M
-$2.1M
Ownership & Float
Insider Ownership
26.4%
Institutional Ownership
22.6%
Short Float
0.5%
% of All Funds Holding
0.38%
Number of Funds Holding
31
Current Moving Averages
Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.
Timeframe
SMA
Value
Trend Context
Weekly
10-Week SMA
$2.87
Near-term / short-term trend
Weekly
40-Week SMA
$4.13
Medium-term trend
Weekly
80-Week SMA
$4.52
Cyclical trend (business cycle)
Weekly
200-Week SMA
$6.08
Secular trend (multi-year)
Monthly
10-Month SMA
$4.04
Near-term monthly trend
Monthly
20-Month SMA
$4.51
Medium-term monthly trend
Monthly
40-Month SMA
$5.45
Secular monthly trend
Volume Shelves — Support & Resistance
Trend Edge identifies volume shelves: price zones where historically elevated trading volume
creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative
volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.
Price Level
Type
Volume Ratio
Age
$3.10
resistance
1.13x
0 months ago
$7.00
resistance
1.07x
25 months ago
Historical Earnings Reactions (34 events)
Timeframe
Avg Return
Median
Win Rate
Best
Worst
Gap
-0.10%
0.00%
47.06%
8.43%
-16.50%
1 Day
-1.48%
0.00%
41.18%
11.51%
-23.40%
1 Week
0.55%
-5.86%
35.29%
84.26%
-27.15%
2 Weeks
2.06%
-2.22%
38.24%
97.96%
-34.36%
1 Month
-1.22%
-3.76%
38.24%
94.81%
-41.62%
Next earnings: August 13, 2026 (13 days away)
Seasonality & Day-of-Week Patterns
Monthly Seasonality
Month
Avg Return
Win Rate
Samples
Jan
11.3%
75.0%
8
Feb
1.6%
50.0%
8
Mar
-13.4%
12.5%
8
Apr
-6.8%
33.3%
9
May
-5.6%
33.3%
9
Jun
-6.6%
22.2%
9
Jul
5.8%
62.5%
8
Aug
10.0%
37.5%
8
Sep
-5.6%
50.0%
8
Oct
-9.3%
37.5%
8
Nov
14.9%
50.0%
8
Dec
5.7%
62.5%
8
Day-of-Week Tendencies
Day
Avg Return
Win Rate
Samples
Monday
0.13%
41.9%
396
Tuesday
0.13%
42.7%
433
Wednesday
0.01%
41.0%
429
Thursday
-0.46%
38.2%
422
Friday
0.41%
45.6%
421
Top Institutional Holders
Institutional holder breakdown coming soon.
Total institutional ownership: 22.6%
Insider Transactions — Smart Summary
Total insider ownership: 26.4%
Founder-led management: Mark Christianson (Co-Founder, Business Development Director, and Medical Sales Liaison)
Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Neuroone Medical Technologies Corp
(NMTC) powered by Claude Opus — Anthropic's most capable AI model.
The analysis covers five layers:
technical analysis (near-term, medium-term, cyclical, and secular trend, momentum,
volume shelf support and resistance, breakout and breakdown signals),
qualitative analysis (business model, competitive moat, sector dynamics),
insider sentiment (buy and sell signals from executive and director transactions),
share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and
fundamental analysis (valuation, revenue growth, profit margin, earnings quality).
AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit,
stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward.
Whether you are building a long position, initiating a short, or looking for a reversal setup,
AI Consult identifies the highest-probability signal from the current trend.